Connection
Tarak Srivastava to Angiotensin II Type 1 Receptor Blockers
This is a "connection" page, showing publications Tarak Srivastava has written about Angiotensin II Type 1 Receptor Blockers.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.163 |
|
|
|
-
Trachtman H, Nelson P, Adler S, Campbell KN, Chaudhuri A, Derebail VK, Gambaro G, Gesualdo L, Gipson DS, Hogan J, Lieberman K, Marder B, Meyers KE, Mustafa E, Radhakrishnan J, Srivastava T, Stepanians M, Tesar V, Zhdanova O, Komers R. DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS. J Am Soc Nephrol. 2018 11; 29(11):2745-2754.
Score: 0.163